<div><p>Background</p><p>Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elite control (EC) of HIV infection. Although numerous definitions of EC exist, it is not clear which, if any, best identify this rare phenotype.</p><p>Methods</p><p>We assessed a number of EC definitions used in the literature using CASCADE data of 25,692 HIV seroconverters. We estimated proportions maintaining EC of total ART-naïve follow-up time, and disease progression, comparing to non-EC. We also examined HIV-RNA and CD4 values and CD4 slope during EC and beyond (while ART naïve).</p><p>Results</p><p>Most definitions classify ∼1% as ECs with median HIV-RNA 43–903 copies/ml and median CD4>500 cells/mm<sup>3</sup>. Be...
Objective: HIV "elite controllers" (ECs) spontaneously control viral load, but some eventually requi...
human immunodeficiency virus (HIV) elite controllers, or HIV-infected individ-uals who maintain unde...
[Background] The proportion of HIV controllers developing virologic, immunological or clinical progr...
Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elit...
Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elit...
†<p>Individuals in the cohort without adequate follow-up or number of HIV-RNA measurements to classi...
(See the article by Julg et al, on pages 233–238.) Soon after the initial discovery of human immunod...
HIV-1 elite controllers (EC) maintain undetectable viral loads (VL) in the absence of antiretroviral...
HIV-1 elite controllers (EC) maintain undetectable viral loads (VL) in the absence of antiretroviral...
Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control ...
<p>Example: 95 seroconverters were classified as EC by definition F of whom 25 (26%) were classified...
Abstract Background Elite controllers (EC) are a rare subset of HIV infected individuals who control...
<div><p>Objective</p><p>HIV “elite controllers” (ECs) spontaneously control viral load, but some eve...
††<p>Number of Elites making it to 10 years follow up without experiencing composite endpoint and nu...
BackgroundElite controllers (EC), a small subset of the HIV-positive population (< 1%), suppress ...
Objective: HIV "elite controllers" (ECs) spontaneously control viral load, but some eventually requi...
human immunodeficiency virus (HIV) elite controllers, or HIV-infected individ-uals who maintain unde...
[Background] The proportion of HIV controllers developing virologic, immunological or clinical progr...
Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elit...
Understanding the mechanisms underlying viral control is highly relevant to vaccine studies and elit...
†<p>Individuals in the cohort without adequate follow-up or number of HIV-RNA measurements to classi...
(See the article by Julg et al, on pages 233–238.) Soon after the initial discovery of human immunod...
HIV-1 elite controllers (EC) maintain undetectable viral loads (VL) in the absence of antiretroviral...
HIV-1 elite controllers (EC) maintain undetectable viral loads (VL) in the absence of antiretroviral...
Elite controllers (EC) represent a small subset of HIV-1-infected people that spontaneously control ...
<p>Example: 95 seroconverters were classified as EC by definition F of whom 25 (26%) were classified...
Abstract Background Elite controllers (EC) are a rare subset of HIV infected individuals who control...
<div><p>Objective</p><p>HIV “elite controllers” (ECs) spontaneously control viral load, but some eve...
††<p>Number of Elites making it to 10 years follow up without experiencing composite endpoint and nu...
BackgroundElite controllers (EC), a small subset of the HIV-positive population (< 1%), suppress ...
Objective: HIV "elite controllers" (ECs) spontaneously control viral load, but some eventually requi...
human immunodeficiency virus (HIV) elite controllers, or HIV-infected individ-uals who maintain unde...
[Background] The proportion of HIV controllers developing virologic, immunological or clinical progr...